Align Technology (NASDAQ: ALGN) , the company behind the Invisalign system of clear aligners, reported a whopping $1.0 billion in topline revenue during the second quarter. This was more than expected and the first time in the company's history that topline revenue reached a 10-figure sum.
Shares of this popular healthcare stock have soared 135% over the past year and investors want to know if it can keep climbing. Let's take a closer look to find out if Align Technology is a good buy right now.
Image source: Getty Images.
For further details see:
Is Align Technology a Buy After a Blowout Second Quarter?